AFIB News and Press, Acutus Medical Inc. From 03/31/22

CARLSBAD, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the 21 s...

Gainers: Longeveron (LGVN) +62%. Clovis Oncology (CLVS) +61%. Icosavax (ICVX) +26%. Integrated Media Technology (IMTE) +28%. SAB Biotherapeutics (SABS) +21%. Local Bounti (LOCL) +21%. CPS Technologies (CPSH) +18%. Vector Group (VGR) +17%. Nano-X Imaging (NNOX) +16%. Vertex Energy (VTNR) +16%....

Gainers: Clovis Oncology CLVS +68%. Longeveron LGVN +36%. Icosavax (ICVX) +27%. Creative Medical Technology (CELZ) +25%. Nano-X Imaging NNOX +22%. Losers: Clarus Therapeutics CRXT -27%. Acutus Medical AFIB -18%. Vyant Bio VYNT -15%. Phree...

Image source: The Motley Fool. Acutus Medical, Inc. (NASDAQ: AFIB) Q4 2021 Earnings Call Mar 30, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Acutus Medical, Inc. (AFIB) Q4 2021 Earnings Call Transcript

Acutus Medical, Inc. (AFIB) Q4 2021 Earnings Conference Call March 30, 2022, 4:30 PM ET Company Participants Vince Burgess – President and Chief Executive Officer David Roman – Chief Financial Officer Caroline Corner – Investor Relations Conference Call Participants Robbi...

Acutus Medical press release (NASDAQ:AFIB): Q4 Non-GAAP EPS of -$1.00 misses by $0.24. Revenue of $4.36M (+69.6% Y/Y) beats by $0.15M. Shares -16.58%. For further details see: Acutus Medical Non-GAAP EPS of -$1.00 misses by $0.24, revenue of $4.36M beats by $0.15M

CARLSBAD, Calif., March 30, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the fourt...

Research Highlights: The more fires they respond to, the higher the risk of atrial fibrillation or AFib – a common irregular heart rhythm – among firefighters, according to a survey of more than 10,000 active U.S. firefighters. After adjusting for atrial fibrillation risk f...

SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced that a deadline is coming up on April 4th in the lawsuit that was filed for certain investors in NASDAQ: AFIB shares. Investors who have losses of over $50,000 from their investment in shares of Ac...

CARLSBAD, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today updated the planned release of...